Login
$CMPX
$0.69 +$0.03 (4.07%) After hours

$CMPX 8-K/A SEC Filings

Filed On Filing
05 Aug 2021 8-K/A: Financial Statements and Exhibits

The accompanying notes are an integral part of these unaudited condensed financial statements.

31 Jul 2020 8-K/A: Completion of Acquisition or Disposition of Assets

We are a clinical-stage biopharmaceutical company developing proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. Our immuno-oncology product candidates include...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support